Communiqués Bio Vitos Pharma AB

Actions

BIOVIT

SE0009320278

Marché Fermé - Nasdaq Stockholm Autres places de cotation 18:00:00 26/06/2024			Varia. 5j.	Varia. 1 janv.
0,109 ^SEK	+0,93%		-11,38%	-54,20%

13/05	Bio Vitos Pharma AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
14/02	Bio Vitos Pharma AB (publ) annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer	12/02	AQ
The European Patent Office EPO grants patent that is important to Bio Vitos Pharma	20/12	AQ
Hemcheck completes the transaction with Bio Vitos	20/10/23	AQ
Hemcheck has received a first order from its distributor Astemed	15/05/23	AQ
Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement	04/05/23	AQ
Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)	26/04/23	AQ
Hemcheck has received a first order from the university hospital Charité in Berlin	05/04/23	AQ
Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week	16/03/23	AQ
Hemcheck has received a first follow up order from its Finnish distributor	13/03/23	AQ
Hemcheck has received an additional follow up order from its UK distributor	02/03/23	AQ
Hemcheck receives follow up order from research program in the United States	28/02/23	AQ
Correction: DBP International AB: investee company Bio Vitos has yesterday reached agreement with Hemcheck	08/02/23	AQ
DBP International AB: investee company Bio Vitos has today reached agreement with Hemcheck	08/02/23	AQ
Hemcheck has received a follow up order from its French distributor	03/02/23	AQ
Hemcheck has received a follow up order from its UK distributor	01/02/23	AQ
Hemcheck has received a first order from a leading hospital in Iceland	24/01/23	AQ
Hemcheck has received a follow up order from its Spanish distributor	23/01/23	AQ
Hemcheck has received another follow up order from its Irish distributor	17/01/23	AQ
Hemcheck extends agreement regarding previously communicated project with Region Skåne	03/01/23	AQ
Hemcheck has received a follow up order from its Irish distributor	20/12/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Bio Vitos Pharma AB

Actions

BIOVIT

SE0009320278

Communiqués

Filtres